Homology Medicines, Inc. | TalkMarkets | Page 1
No data available
No data available

People who follow this stock (13)

Latest Posts

About This Stock More About This Stock
Supernus (SUPN) Moves 5.7% Higher: Will This Strength Last?
Article By: Zacks Investment Research
Monday, February 21, 2022 5:33 AM EDT
Supernus Pharmaceuticals shares soared 5.7% in the last trading session to close at $32.90. The move was backed by solid volume with far more shares changing hands than in a normal session.
In this article: SUPN Also: FIXX
Read
High Flyers At Much Lower Altitudes
Article By: Bespoke Investment Group
Friday, May 14, 2021 2:12 PM EDT
Stocks with extreme valuations have taken a serious haircut since the space peaked on February 22nd.
In this article: CRMD, INO, DMTK, ARCT, WKHS, ATOM, EVFM, FIXX, SPCE
Read
3 Promising Gene Therapy Stocks
Article By: Tarun Chandra, CFA
Saturday, May 25, 2019 9:45 PM EDT
Investor interest in gene therapy companies has been on the rise. Here is a look at 3 promising small cap gene therapy companies.
In this article: BOLD, VYGR, QURE Also: SRPT, PTCT, BLUE, ONCE, EDIT, NTLA, CRSP, RGNX, SLDB, FIXX, MGTX, NVS, RHHBY, GOOG, ACAD, ARNA, ARRY, CBPO, PCRX, AMRN, SAGE, MRNA, GWPH, ASND, RARX, BHVN, MRTX, DNLI, CHRS, MDCO, ARWR, ZIOP, TGTX, PTLA, GBT, AXSM
Read

Latest Tweets for $FIXX

No tweets yet!

PARTNER HEADLINES